Department of Chemotherapy II
This department was initially founded on March 3, 2014. The experience of the recent years shows that the specialists operating in the narrower framework can obtain more sucessful and rational results. From this viewpoint, the major direction of the clinical work consists of chemical, medical therapy of the malignant tumor of the women breast cancer and reproductive organs (ovary, uterus, cervix uteri).
However, the hormonal and target therapy of the tumors with the same localization is successfully conducted in this deparment. The employees of the department are using standard chemotherapy protocols in the treatment of the disease by benefiting the recommendations of the such influensive organizations as NCCN, ESMO, ASCO.
Apart from this, the employees of the department are in close cooperation with Moleculary Oncological Laboratory established in the most modern level. The chemicals intended to prescribe for the patients, determined as a result of conducting apropriate analysis in the laboratory are known how useful for the organism beforehand. So, the patients are not exposed by the unnecessary toxical influence as well as the medical products are well saved.